Benzylpiperazine: the New Zealand legal perspective
Article first published online: 30 JUN 2011
Copyright © 2011 John Wiley & Sons, Ltd.
Drug Testing and Analysis
Special Issue: New Psychoactive Substances
Volume 3, Issue 7-8, pages 428–429, July - August 2011
How to Cite
Bassindale, T. (2011), Benzylpiperazine: the New Zealand legal perspective. Drug Test Analysis, 3: 428–429. doi: 10.1002/dta.314
- Issue published online: 20 JUL 2011
- Article first published online: 30 JUN 2011
In 2005 the New Zealand Government created a new schedule of ‘Restricted Substances’ under the Misuse of Drugs Act (1975). Benzylpiperazine was the first drug to be classified as what became known informally as ‘Class D’. The rationale behind that decision and the subsequent reclassification of benzylpiperazine to Class C, in 2008, is discussed.